Tuesday, January 27, 2015

isis targeting RNA (“RNA Therapeutics”) resulting in the silencing of disease causing genes (‘gene silencing’). rnaitherapeutics.blogspot.com


Nature Biotechnology on Twitter: "Triantennary GalNAc ...

https://twitter.com/naturebiotech/status/489911122729123840
Jul 17, 2014 - Triantennary GalNAc conjugated to Isis' antisense oligos enhances ... Don't miss any updates from Nature Biotechnology. © 2015 Twitter ...
  • Companies To Develop Antisense Drug for Myotonic ...

    quest.mda.org/.../companies-develop-an...
    Muscular Dystrophy Association
    Loading...
    Sep 10, 2013 - Isis and Biogen Idec are collaborating to develop antisense drugs for ... Dystrophy Clinical Research Network and a recently funded "natural ...
  • RNAi Therapeutics

    rnaitherapeutics.blogspot.com/
    7 days ago - In general, with RNAi and antisense therapeutics, what you see with .... while ISIS can leverage the same for antisense therapeutics against factor XI .... in limiting the claimed natural ability of monoclonal antibodies to more ...
  • For More Information

    Find out more about the ISIS-TTRRX trial or have your questions answered by contacting a trial location.
    Contact Us


    Share with friends:

    Read more at http://ttrstudy.com/about-the-drug/antisense-oligonucleotide-technology/#Pw76L1K3z87wGfRQ.99

    No comments:

    Post a Comment